Agonistes de récepteur S1P1 à utiliser dans le traitement de la maladie de Crohn
- 专利权人:
- Almirall; S.A.
- 发明人:
- 申请号：
- EP10382313.4
- 公开号：
- EP2455081A1
- 申请日:
- 2010.11.23
- 申请国别(地区):
- EP
- 年份:
- 2012
- 代理人:
- 摘要：
- a S1P1 receptor agonist of formula (I), or a pharmaceutically acceptable salt, or solvate, or N-oxide, or stereoisomer or deuterated derivate thereof, for use in the treatment of inflammatory bowel disease, in particular Crohn's disease.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASES
- TREATMENT OF INFLAMMATORY BOWEL DISEASE
- ORAL PEPTIDE INHIBITORS OF INTERLEUKIN 23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASES
- Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
- Methods of treating inflammatory bowel disease using IL-22 Fc fusion proteins
